Back to Search Start Over

Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies

Authors :
Mancini, N.
Canducci, F.
Carletti, S.
Berardinelli, E.
Serafini, G.
Grieco, A.
Perotti, M.
Malcangi, G.
Danieli, M. G.
Pietro VARALDO
Clementi, M.
Burioni, R.
Mancini, Nicasio
Canducci, F
Carletti, S
Berardinelli, E
Serafini, G
Grieco, A
Perotti, M
Malcangi, G
Danieli, Mg
Varaldo, Pe
Clementi, Massimo
Burioni, Roberto
Source :
Scopus-Elsevier, 17 (2003): 183–187., info:cnr-pdr/source/autori:Mancini, N.; Canducci, F.; Carletti, S.; Berardinelli, E.; Serafini, G.; Grieco, A.; Perotti, M.; Malcangi, G.; Danieli, M.G.; Varaldo, P.E.; Clementi, M.; Burioni, R./titolo:Heterogeneity of the humoral anti-HCV%2FE2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV%2FE2 human monoclonal antibodies/doi:/rivista:/anno:2003/pagina_da:183/pagina_a:187/intervallo_pagine:183–187/volume:17
Publication Year :
2003

Abstract

A complete understanding of the molecular features of humoral immune response could be of pivotal importance in the management of persistent viruses as HCV. In this study, 24 HCV-positive samples, characterized by classical virological parameters, are evaluated using a new assay for the quantitation of antibody subpopulations directed against discrete epitopes on surface glycoprotein E2, a key viral protein. The results, besides confirming the usefulness of this new approach, highlight the extreme heterogeneity of anti-HCV/E2 response as far as single epitopes are concerned. The specific epitopes under study are also demonstrated to be widely shared among different genotypes.

Details

ISSN :
0393974X
Volume :
17
Issue :
2
Database :
OpenAIRE
Journal :
Journal of biological regulators and homeostatic agents
Accession number :
edsair.pmid.dedup....c4aa1fbdb8c8bb46c31fa03cd3398055